Forget Big Tech's Rough 2026. Defense Stocks Are the Year's Breakout, Up ~52% While the S&P Fell

ITA has $13.91B in assets and a 0.38% expense ratio, but its YTD return of 10.73% has lagged XAR’s 17.27% because cap-weighting leaves the fund heavily exposed to GE Aerospace (19.03%), RTX (16.55%), and Boeing (8.91%). The article argues that equal-weighted XAR better captures the rearmament trade, with 1-year returns of 43.49% versus 32.52% for ITA and 10-year gains of 446.61% versus 323.98%. The setup is constructive for defense exposure overall, but the main issue is fund construction and relative performance rather than a fresh catalyst.

Analysis

The key signal is not that defense is weak, but that the dominant ETF wrapper is misclassifying the trade. Cap-weighted exposure is still letting commercial aerospace and turnaround stories dilute the rearmament factor, so the market is paying the sector multiple without getting clean defense beta. That creates a structural dispersion opportunity: suppliers with direct budget linkage and smaller index weights can outperform even if headline sector performance looks merely average.

Second-order effects favor the mid/smaller suppliers and selected equipment names over the primes with execution baggage. If procurement stays elevated, the bottleneck shifts from prime demand to sub-tier capacity, testing lead times, certification pipelines, and working capital; that tends to reward names like AVAV and TDG earlier in the cycle because they can convert order flow into earnings faster than the platform primes. Meanwhile, BA remains a hidden drag on any cap-weighted basket because its free-cash-flow burden absorbs investor attention and constrains multiple expansion elsewhere in the fund.

The market’s complacency is in treating this as a one-factor macro trade when it is really a positioning and benchmark-constitution trade. The biggest reversal risk is not a sudden collapse in defense spending, but a rotation back toward commercial aerospace cyclicality if GE keeps compounding and Boeing stabilizes, which would mechanically reassert the cap-weighted ETF’s upside. Conversely, any ceasefire or appropriations delay would hit the equal-weight basket harder near term because the smaller defense names have less non-defense ballast and are priced for cleaner execution.

Contrarian angle: the consensus is overvaluing thematic purity and undervaluing balance-sheet and cash-conversion quality. XAR has been winning because breadth matters, but if the cycle matures, the highest-quality compounders within defense-tech-adjacent exposure, especially PLTR and select sub-tier industrials, can keep working even if the broad rearmament basket stalls.

Key Decisions for Investors

• Rotate core exposure from ITA to XAR over 1-4 weeks in tax-advantaged accounts; expected benefit is cleaner defense beta and less Boeing drag, with the main risk being a renewed GE/BA-led cap-weighted rally.
• Pair trade: long AVAV / short BA for 3-6 months; thesis is that order-flow names with operating leverage should outperform a negative-FCF turnaround, with asymmetric downside if BA needs more capital or delivery issues reappear.
• Add a small satellite long PLTR versus LMT or GD for 6-12 months; the trade captures defense-tech budget share and software re-rating while avoiding hardware execution risk, but only as a low-conviction pair because valuation is already rich.
• Use pullbacks in XAR or individual names to add on weakness rather than chase strength; rearmament baskets tend to mean-revert on ceasefire headlines, but procurement backlogs support a multi-quarter buy-the-dip setup.
• In taxable accounts, keep ITA and direct new capital to XAR or AVAV; this preserves cost basis while gradually shifting exposure toward the names with better second-order earnings leverage.